兰州大学学报(医学版)
蘭州大學學報(醫學版)
란주대학학보(의학판)
JOURNAL OF LANZHOU UNIVERSITY(MEDICAL SCIENCES)
2015年
3期
14-19
,共6页
冯燕海%朱红玲%录亚鹏%李宁
馮燕海%硃紅玲%錄亞鵬%李寧
풍연해%주홍령%록아붕%리저
神经肽FF%内吗啡肽2%水浴甩尾实验%福尔马林痛实验
神經肽FF%內嗎啡肽2%水浴甩尾實驗%福爾馬林痛實驗
신경태FF%내마배태2%수욕솔미실험%복이마림통실험
neuropeptide FF%endomorphin-2%tail-immersion test%Formalin test
目的:研究神经肽FF (NPFF)对内吗啡肽2(EM-2)在急性痛与炎症痛中镇痛作用的调节。方法雄性昆明系小鼠,体重(20±2) g,侧脑室埋管后,水浴甩尾实验和福尔马林痛实验各随机分为8组,即盐水对照组、EM-2组、NPFF受体拮抗剂RF9组、EM-2+RF9组、低剂量NPFF+EM-2组、中剂量NPFF+EM-2组、高剂量NPFF+EM-2组、高剂量NPFF+RF9+EM-2组,每组8只小鼠。侧脑室注射药物NPFF、EM-2和RF9。小鼠水浴甩尾实验研究NPFF对EM-2中枢镇痛的调节作用,福尔马林痛实验研究NPFF对EM-2急性痛与炎症痛镇痛的调节作用。结果水浴甩尾实验结果显示,EM-27.5 nmol可延长小鼠的甩尾潜伏期, NPFF 5,10,15 nmol可剂量依赖性增强EM-2的镇痛作用。福尔马林痛实验结果显示,EM-215 nmol对第一相急性痛与第二相炎症痛均有镇痛作用, NPFF 10,15,20 nmol可剂量依赖性增强EM-2的镇痛作用。在2个实验中,RF9与NPFF联合给药后,RF9能拮抗NPFF对EM-2镇痛的增强作用。结论在小鼠水浴甩尾实验和福尔马林痛实验中,NPFF通过作用于NPFF受体拮抗剂RF9,剂量依赖性增强EM-2对急性痛和炎症痛的镇痛作用。
目的:研究神經肽FF (NPFF)對內嗎啡肽2(EM-2)在急性痛與炎癥痛中鎮痛作用的調節。方法雄性昆明繫小鼠,體重(20±2) g,側腦室埋管後,水浴甩尾實驗和福爾馬林痛實驗各隨機分為8組,即鹽水對照組、EM-2組、NPFF受體拮抗劑RF9組、EM-2+RF9組、低劑量NPFF+EM-2組、中劑量NPFF+EM-2組、高劑量NPFF+EM-2組、高劑量NPFF+RF9+EM-2組,每組8隻小鼠。側腦室註射藥物NPFF、EM-2和RF9。小鼠水浴甩尾實驗研究NPFF對EM-2中樞鎮痛的調節作用,福爾馬林痛實驗研究NPFF對EM-2急性痛與炎癥痛鎮痛的調節作用。結果水浴甩尾實驗結果顯示,EM-27.5 nmol可延長小鼠的甩尾潛伏期, NPFF 5,10,15 nmol可劑量依賴性增彊EM-2的鎮痛作用。福爾馬林痛實驗結果顯示,EM-215 nmol對第一相急性痛與第二相炎癥痛均有鎮痛作用, NPFF 10,15,20 nmol可劑量依賴性增彊EM-2的鎮痛作用。在2箇實驗中,RF9與NPFF聯閤給藥後,RF9能拮抗NPFF對EM-2鎮痛的增彊作用。結論在小鼠水浴甩尾實驗和福爾馬林痛實驗中,NPFF通過作用于NPFF受體拮抗劑RF9,劑量依賴性增彊EM-2對急性痛和炎癥痛的鎮痛作用。
목적:연구신경태FF (NPFF)대내마배태2(EM-2)재급성통여염증통중진통작용적조절。방법웅성곤명계소서,체중(20±2) g,측뇌실매관후,수욕솔미실험화복이마림통실험각수궤분위8조,즉염수대조조、EM-2조、NPFF수체길항제RF9조、EM-2+RF9조、저제량NPFF+EM-2조、중제량NPFF+EM-2조、고제량NPFF+EM-2조、고제량NPFF+RF9+EM-2조,매조8지소서。측뇌실주사약물NPFF、EM-2화RF9。소서수욕솔미실험연구NPFF대EM-2중추진통적조절작용,복이마림통실험연구NPFF대EM-2급성통여염증통진통적조절작용。결과수욕솔미실험결과현시,EM-27.5 nmol가연장소서적솔미잠복기, NPFF 5,10,15 nmol가제량의뢰성증강EM-2적진통작용。복이마림통실험결과현시,EM-215 nmol대제일상급성통여제이상염증통균유진통작용, NPFF 10,15,20 nmol가제량의뢰성증강EM-2적진통작용。재2개실험중,RF9여NPFF연합급약후,RF9능길항NPFF대EM-2진통적증강작용。결론재소서수욕솔미실험화복이마림통실험중,NPFF통과작용우NPFF수체길항제RF9,제량의뢰성증강EM-2대급성통화염증통적진통작용。
Objective To investigate the modulation of neuropeptide FF (NPFF) on endomorphin-2 (EM-2) induced antinociception in acute and inflammatory pain. Methods Male Kunming mice weighing (20 ± 2)g (n=128) were divided into eight groups in the mouse tail-immersion test (n=64) and formalin test (n=64), including saline group, EM-2 group, RF9 group (NPFF antagonist), EM-2+RF9 group, low dose NPFF+EM-2 group, medium dose NPFF+EM-2 group, high dose NPFF+EM-2 group, high dose NPFF+RF9+EM-2 group, and each group contains eight mice. Drugs (NPFF, EM-2 and RF9) were injected into the lateral ventricle through the cannula. The mouse tail-immersion test was used to investigate the modulating effects of NPFF on EM-2-induced central antinociception. The mouse Formalin test was used to investigate the modulation of NPFF on EM-2 induced antinociceptive effects in acute and inflammatory pain. Results In the mouse tail-immersion test, NPFF (5, 10, 15 nmol, i.c.v.) dose-dependently enhanced the central antinociception of EM-2 (7.5 nmol, i.c.v.). Furthermore, in the mouse Formalin test, NPFF (10, 15, 20 nmol, i.c.v.) also dose-dependently augmented the antinociceptive effcet caused by intracerebroventricular injection of 15 nmol EM-2 in Forma-lin-induced acute and inflammatory pain. Moreover, these modulating effect of NPFF on EM-2 were marked-ly prevented by pretreatment with NPFF receptors selective antagonist RF9. Conclusion NPFF (i.c.v.) dose-dependently can improve the EM-2-induced central antinociception in acute and inflammatory pain by NPFF receptors.